Novartis AG
NVSEF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001114448
No open-market purchases or sales by Novartis AG insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $6.28M in total; no superinvestor holds it.
Other share classesNVS
Q2 2023 vs. Q1 2023
How the institutions holding Novartis AG changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 3 | 5 | +2 |
| Shares | 623.0K | 723.9K | +100.8K (+16.2%) |
| Value | $57.0M | $72.8M | +$15.7M (+27.6%) |
New holders (2)
Institutions that held Novartis AG at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Partners Capital Investment Group, LLP | 64,026 | $6.44M | 0.14% |
| Kennedy Capital Management, Inc. | 14,546 | $1.46M | 0.03% |
Sold out (0)
Institutions that held Novartis AG at the end of Q1 2023 and filed for Q2 2023 without it.
None.